BridgeMD
New treatment option for Surgery
Official title A Study of Bevonescein in Patients Undergoing Abdominopelvic Surgery
ClinicalTrials.gov ID: NCT06662097
What this study is testing
What is Bevonescein?
Bevonescein is an investigational medicine, given as an infusion into a vein, being studied as a potential treatment for surgery.
Also referred to as ALM-488.
Plain-language explanation of the investigational treatment - it is being studied and is not an approved or proven therapy. The study team can confirm the details.
- What it's testing
- Feasibility study of Bevonescein to highlight Nerves and Ureter in patients undergoing Minimally Invasive Surgery
- Phase 2: a mid-size study of how well it works
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 and older. Healthy volunteers may be eligible.
You may be able to join if
- Must be a minimum of 18 years of age
- Study participant is planning to proceed with surgery
- Willing to provide informed consent
- Sexually active patients must be willing to use an acceptable form of contraceptive while participating and 30 days after.
- Females of childbearing potential must have a negative pregnancy test at screening and during the study.
You likely can't join if
- Patient has had prior surgery at the intended surgical site.
- Patient has abnormal cardiac rhythm not controlled by medication.
- Patient has moderate to severe renal impairment.
- Patient has a history of fluorescein allergy.
- Patient has a history of drug-related anaphylactic.
- Presence of a concurrent disease or condition that may interfere with study participation.
See the full eligibility criteria
- Must be a minimum of 18 years of age
- Study participant is planning to proceed with surgery
- Willing to provide informed consent
- Sexually active patients must be willing to use an acceptable form of contraceptive while participating and 30 days after.
- Females of childbearing potential must have a negative pregnancy test at screening and during the study.
- Patient has had prior surgery at the intended surgical site.
- Patient has abnormal cardiac rhythm not controlled by medication.
- Patient has moderate to severe renal impairment.
- Patient has a history of fluorescein allergy.
- Patient has a history of drug-related anaphylactic.
- Presence of a concurrent disease or condition that may interfere with study participation.
- Presence or history of any condition that, in the view of the investigator, places the patient at high risk of treatment compliance.
- Use of any Investigational Product or investigational medial device within 30 days prior to screening.
The study team makes the final eligibility decision.
Where it's taking place
- San Diego, California, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years and older. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include San Diego, California, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.